Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.29 | N/A |
| PEG Ratio (TTM) | -1.81 | N/A |
| P/S Ratio (TTM) | 0.74 | N/A |
| P/B Ratio (TTM) | 1.41 | N/A |
| P/FCF Ratio (TTM) | 8.16 | N/A |
| Price to 5YR AVG Earnings Ratio | 19.33 | N/A |
| Price to 5YR AVG FCF Ratio | -22.79 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.80% | N/A |
| ROE (TTM) | 8.37% | N/A |
| Net Profit Margin (TTM) | 4.25% | N/A |
| ROIC 5YR AVG | 4.85% | N/A |
Growth (90%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 118.84% | 741.28% | 492.86% |
| Revenue | 1.31% | 10.95% | 18.75% |
| Net Income | 108.58% | 717.68% | 476.63% |
| Cash Flow | 281.30% | 13,562.38% | 8,141.53% |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.59 | N/A |
| Quick Ratio (TTM) | 0.57 | N/A |
| D/E Ratio (TTM) | 0.64 | N/A |
| Interest Coverage (TTM) | 2.18 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.32 | N/A |
| LTL to 5YR AVG FCF | -16.83 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.53% | N/A |